Bill to require parental review of FDA medication guides for psychotropic drugs draws opposition from Medicaid officials, medical society

The Senate Health and Human Services committee heard testimony on House Bill 732, which would require prescribers to present FDA medication guides and obtain written informed consent from a parent or guardian before prescribing psychotropic drugs to Medicaid‑covered children.

Rep. Clayne Cordelli introduced the bill, saying parents should be aware of risks associated with psychotropic medications, including suicidal ideation, aggression and other serious side effects that are described in FDA medication guides. "Parents should be aware of those risks before allowing their children to take them," Cordelli said.

Officials from the Department of Health and Human Services provided an informational presentation and raised multiple practical concerns. Jonathan Ballard, chief medical officer at DHHS, said the state27s Medicaid program has long treated medical care agnostically to payer type and that adding a payer‑specific requirement creates operational difficulties. He said…